• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫乳头状浆液性癌:后续或同时发生乳腺癌的风险增加。

Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.

作者信息

Geisler J P, Sorosky J I, Duong H L, Buekers T E, Geisler M J, Sood A K, Anderson B, Buller R E

机构信息

Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA.

出版信息

Gynecol Oncol. 2001 Dec;83(3):501-3. doi: 10.1006/gyno.2001.6445.

DOI:10.1006/gyno.2001.6445
PMID:11733962
Abstract

OBJECTIVE

Some women with endometrial cancer may be at increased risk for developing breast cancer. The histologic type of endometrial cancer associated with synchronous or subsequent breast cancer has not been clearly established. Our purpose was to determine if a certain histologic type of endometrial cancer was associated with an increased risk of synchronous or subsequent breast cancer.

METHODS

The University of Iowa Hospitals and Clinics tumor registry was queried to ascertain all patients with the diagnosis of uterine cancer from January 1, 1983, to December 31, 1994. Statistics were performed utilizing SPSS for Windows version 9.0 (SPSS Inc., Chicago, IL), including Student's t tests and chi(2) tests.

RESULTS

Five hundred ninety-two patients had endometrial adenocarcinoma during the study period. Five hundred thirty-six women had endometrioid adenocarcinoma, 23 women had papillary serous carcinoma (UPSC), 21 women had adenosquamous carcinoma, 10 women had clear-cell carcinoma, and 1 woman each had mucinous or squamous carcinoma. Twelve patients had previously been diagnosed with breast carcinomas. Twenty-five patients were diagnosed with breast cancer either concurrently or subsequent to their diagnosis of endometrial cancer. Synchronous or subsequent breast cancers developed in 3.2% of patients with endometrioid carcinoma and in 25% of patients with UPSC (P < 0.001).

CONCLUSION

Patients with UPSC have an increased risk of development of breast cancer as compared to patients with endometrioid adenocarcinoma of the uterus.

摘要

目的

一些子宫内膜癌女性患乳腺癌的风险可能会增加。与同步或后续乳腺癌相关的子宫内膜癌组织学类型尚未明确确定。我们的目的是确定某种组织学类型的子宫内膜癌是否与同步或后续乳腺癌风险增加相关。

方法

查询爱荷华大学医院及诊所肿瘤登记处,以确定1983年1月1日至1994年12月31日期间所有诊断为子宫癌的患者。使用SPSS for Windows 9.0版(SPSS公司,伊利诺伊州芝加哥)进行统计分析,包括Student's t检验和卡方检验。

结果

在研究期间,592例患者患有子宫内膜腺癌。536例女性患有子宫内膜样腺癌,23例女性患有乳头状浆液性癌(UPSC),21例女性患有腺鳞癌,10例女性患有透明细胞癌,1例女性分别患有黏液性或鳞状癌。12例患者先前被诊断患有乳腺癌。25例患者在诊断子宫内膜癌的同时或之后被诊断患有乳腺癌。子宫内膜样癌患者中3.2%发生同步或后续乳腺癌,UPSC患者中25%发生同步或后续乳腺癌(P<0.001)。

结论

与子宫子宫内膜样腺癌患者相比,UPSC患者患乳腺癌的风险增加。

相似文献

1
Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.子宫乳头状浆液性癌:后续或同时发生乳腺癌的风险增加。
Gynecol Oncol. 2001 Dec;83(3):501-3. doi: 10.1006/gyno.2001.6445.
2
Relationship between tamoxifen use and high risk endometrial cancer histologic types.他莫昔芬的使用与高危子宫内膜癌组织学类型之间的关系。
Gynecol Oncol. 2009 Jan;112(1):150-4. doi: 10.1016/j.ygyno.2008.08.035. Epub 2008 Oct 19.
3
Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.人激肽释放酶6:子宫浆液性乳头状癌一种新的潜在血清生物标志物。
Clin Cancer Res. 2005 May 1;11(9):3320-5. doi: 10.1158/1078-0432.CCR-04-2528.
4
Association between uterine serous carcinoma and breast cancer.子宫浆液性癌与乳腺癌之间的关联。
Gynecol Oncol. 2004 Jul;94(1):208-11. doi: 10.1016/j.ygyno.2004.04.009.
5
Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.浆液性和子宫内膜样子宫癌患者的危险因素及激素水平
Mod Pathol. 1997 Oct;10(10):963-8.
6
Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes?
Gynecol Oncol. 2006 Sep;102(3):508-12. doi: 10.1016/j.ygyno.2006.01.014. Epub 2006 Feb 17.
7
Uterine papillary serous carcinoma: patterns of metastatic spread.子宫浆液性乳头状癌:转移扩散模式
Gynecol Oncol. 1994 Sep;54(3):264-8. doi: 10.1006/gyno.1994.1208.
8
[Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].[子宫浆液性乳头状癌与子宫内膜乳头状癌:56例临床生物学行为分析]
Zhonghua Fu Chan Ke Za Zhi. 1996 Jan;31(1):8-11.
9
Clinico-cytological study of uterine papillary serous carcinoma.子宫浆液性乳头状癌的临床细胞学研究
Cytopathology. 2005 Jun;16(3):125-31. doi: 10.1111/j.1365-2303.2005.00251.x.
10
High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.子宫内膜癌患者血清白细胞介素-6水平升高与子宫浆液性乳头状组织学有关,后者是一种侵袭性很强且对化疗耐药的子宫内膜癌变体。
Gynecol Oncol. 2005 Jul;98(1):92-8. doi: 10.1016/j.ygyno.2005.03.016.

引用本文的文献

1
Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?子宫内膜癌和乳腺癌的同时诊断——顺序重要吗?
Gynecol Oncol Rep. 2021 Sep 20;38:100863. doi: 10.1016/j.gore.2021.100863. eCollection 2021 Nov.
2
Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?表现为子宫内膜癌的遗传性综合征:病理特征如何有助于风险评估?
Biomed Res Int. 2015;2015:219012. doi: 10.1155/2015/219012. Epub 2015 Jun 16.
3
BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
BRCA1、TP53 和 CHEK2 种系突变与子宫浆液性癌相关。
Cancer. 2013 Jan 15;119(2):332-8. doi: 10.1002/cncr.27720. Epub 2012 Jul 18.
4
Uterine serous carcinoma: increased familial risk for lynch-associated malignancies.子宫浆液性癌:林奇相关恶性肿瘤的家族风险增加。
Cancer Prev Res (Phila). 2012 Mar;5(3):435-43. doi: 10.1158/1940-6207.CAPR-11-0499. Epub 2012 Jan 13.